Literature DB >> 33154094

Protective Effects of Flavonoids in Acute Models of Light-Induced Retinal Degeneration.

Joseph T Ortega1, Tanu Parmar1, Marcin Golczak1, Beata Jastrzebska2.   

Abstract

Degeneration of photoreceptors caused by excessive illumination, inherited mutations, or aging is the principal pathology of blinding diseases. Pharmacological compounds that stabilize the visual receptor rhodopsin and modulate the cellular pathways triggering death of photoreceptors could avert this pathology. Interestingly, flavonoids can modulate the cellular processes, such as oxidative stress, inflammatory responses, and apoptosis, that are activated during retinal degeneration. As we found previously, flavonoids also bind directly to unliganded rod opsin, enhancing its folding, stability, and regeneration. In addition, flavonoids stimulate rhodopsin gene expression. Thus, we evaluated the effect of two main dietary flavonoids, quercetin and myricetin, in ATP-binding cassette subfamily A member 4 -/- /retinol dehydrogenase 8 -/- and wild-type BALB/c mice susceptible to light-induced photoreceptor degeneration. Using in vivo imaging, such as optical coherence tomography, scanning laser ophthalmoscopy, and histologic assessment of retinal morphology, we found that treatment with these flavonoids prior to light insult remarkably protected retina from deterioration and preserved its function. Using high-performance liquid chromatography-mass spectrometry analysis, we detected these flavonoids in the eye upon their intraperitoneal administration. The molecular events associated with the protective effect of quercetin and myricetin were related to the elevated expression of photoreceptor-specific proteins, rhodopsin and cone opsins, decreased expression of the specific inflammatory markers, and the shift of the equilibrium between cell death regulators BCL2-associated X protein (BAX) and B-cell lymphoma 2 toward an antiapoptotic profile. These results were confirmed in photoreceptor-derived 661W cells treated with either H2O2 or all-trans-retinal stressors implicated in the mechanism of retinal degeneration. Altogether, flavonoids could have significant prophylactic value for retinal degenerative diseases. SIGNIFICANCE STATEMENT: Flavonoids commonly present in food exhibit advantageous effects in blinding diseases. They bind to and stabilize unliganded rod opsin, which in excess accelerates degenerative processes in the retina. Additionally, flavonoids enhance the expression of the visual receptors, rod and cone opsins; inhibit the inflammatory reactions; and induce the expression of antiapoptotic markers in the retina, preventing the degeneration in vivo. Thus, flavonoids could have a prophylactic value for retinal degenerative diseases.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33154094      PMCID: PMC7736834          DOI: 10.1124/molpharm.120.000072

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  74 in total

1.  Rhodopsin--advances and perspectives.

Authors:  Kris Palczewski; K P Hofmann; Wolfgang Baehr
Journal:  Vision Res       Date:  2006-12       Impact factor: 1.886

2.  Role of quercetin in protecting ARPE‑19 cells against H2O2‑induced injury via nuclear factor erythroid 2 like 2 pathway activation and endoplasmic reticulum stress inhibition.

Authors:  Sisi Weng; Lei Mao; Yuanyuan Gong; Tao Sun; Qing Gu
Journal:  Mol Med Rep       Date:  2017-07-13       Impact factor: 2.952

3.  Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death.

Authors:  Anne Hanneken; Fen-Fen Lin; Jennifer Johnson; Pamela Maher
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

Review 4.  Chemistry of the retinoid (visual) cycle.

Authors:  Philip D Kiser; Marcin Golczak; Krzysztof Palczewski
Journal:  Chem Rev       Date:  2013-07-11       Impact factor: 60.622

Review 5.  Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes.

Authors:  Paul S-H Park; David T Lodowski; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

6.  The transcription factor neural retina leucine zipper (NRL) controls photoreceptor-specific expression of myocyte enhancer factor Mef2c from an alternative promoter.

Authors:  Hong Hao; Padmaja Tummala; Eduardo Guzman; Raghuveer S Mali; Janina Gregorski; Anand Swaroop; Kenneth P Mitton
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

7.  Photoreceptor proteins initiate microglial activation via Toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal.

Authors:  Hideo Kohno; Yu Chen; Brian M Kevany; Eric Pearlman; Masaru Miyagi; Tadao Maeda; Krzysztof Palczewski; Akiko Maeda
Journal:  J Biol Chem       Date:  2013-04-09       Impact factor: 5.157

8.  Chemokine-mediated inflammation in the degenerating retina is coordinated by Müller cells, activated microglia, and retinal pigment epithelium.

Authors:  Matt Rutar; Riccardo Natoli; R X Chia; Krisztina Valter; Jan M Provis
Journal:  J Neuroinflammation       Date:  2015-01-17       Impact factor: 8.322

9.  Antioxidant activity of polyphenolic myricetin in vitro cell- free and cell-based systems.

Authors:  Abolfazl Barzegar
Journal:  Mol Biol Res Commun       Date:  2016-06

Review 10.  Role of Mitochondrial DNA Damage in ROS-Mediated Pathogenesis of Age-Related Macular Degeneration (AMD).

Authors:  Kai Kaarniranta; Elzbieta Pawlowska; Joanna Szczepanska; Aleksandra Jablkowska; Janusz Blasiak
Journal:  Int J Mol Sci       Date:  2019-05-14       Impact factor: 5.923

View more
  8 in total

Review 1.  Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa.

Authors:  Joseph T Ortega; Beata Jastrzebska
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Mitigating the pro-oxidant state and melanogenesis of Retinitis pigmentosa: by counteracting mitochondrial dysfunction.

Authors:  Giovanni Pagano; Federico V Pallardó; Alex Lyakhovich; Luca Tiano; Marco Trifuoggi
Journal:  Cell Mol Life Sci       Date:  2021-10-31       Impact factor: 9.261

3.  Chromenone derivatives as novel pharmacological chaperones for retinitis pigmentosa-linked rod opsin mutants.

Authors:  Joseph T Ortega; Andrew G McKee; Francis J Roushar; Wesley D Penn; Jonathan P Schlebach; Beata Jastrzebska
Journal:  Hum Mol Genet       Date:  2022-10-10       Impact factor: 5.121

Review 4.  Inherited Retinal Dystrophies: Role of Oxidative Stress and Inflammation in Their Physiopathology and Therapeutic Implications.

Authors:  Isabel Pinilla; Victoria Maneu; Laura Campello; Laura Fernández-Sánchez; Natalia Martínez-Gil; Oksana Kutsyr; Xavier Sánchez-Sáez; Carla Sánchez-Castillo; Pedro Lax; Nicolás Cuenca
Journal:  Antioxidants (Basel)       Date:  2022-05-30

5.  Formulation and Evaluation of SNEDDS Loaded with Original Lipophenol for the Oral Route to Prevent Dry AMD and Stragardt's Disease.

Authors:  Maxime Vincent; Laurianne Simon; Philippe Brabet; Philippe Legrand; Christophe Dorandeu; Josephine Lai Kee Him; Thierry Durand; Céline Crauste; Sylvie Begu
Journal:  Pharmaceutics       Date:  2022-05-10       Impact factor: 6.525

Review 6.  Flavonoids as Potential Anti-Inflammatory Molecules: A Review.

Authors:  Jameel M Al-Khayri; Gandasi Ravikumar Sahana; Praveen Nagella; Biljo V Joseph; Fatima M Alessa; Muneera Q Al-Mssallem
Journal:  Molecules       Date:  2022-05-02       Impact factor: 4.927

7.  (-)-Epicatechin Provides Neuroprotection in Sodium Iodate-Induced Retinal Degeneration.

Authors:  Manjuan Peng; Xuezhi Zhou; Fei Yao; Haibo Li; Weitao Song; Siqi Xiong; Xiaobo Xia
Journal:  Front Med (Lausanne)       Date:  2022-06-27

Review 8.  Quercetin: A Bioactive Compound Imparting Cardiovascular and Neuroprotective Benefits: Scope for Exploring Fresh Produce, Their Wastes, and By-Products.

Authors:  Irshad Ul Haq Bhat; Rajeev Bhat
Journal:  Biology (Basel)       Date:  2021-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.